{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,7,28]],"date-time":"2023-07-28T02:49:10Z","timestamp":1690512550203},"reference-count":43,"publisher":"Oxford University Press (OUP)","issue":"1032","license":[{"start":{"date-parts":[[2011,9,27]],"date-time":"2011-09-27T00:00:00Z","timestamp":1317081600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,10,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n               <jats:sec>\n                  <jats:title>Purpose of the study<\/jats:title>\n                  <jats:p>Distal peripheral neuropathy (DPN) is a troublesome complication of diabetes mellitus (DM). The factors associated with the disease are still incompletely understood. The purpose of this study was to investigate factors associated with vibration perception threshold (VPT) as a marker of DPN in a type 2 diabetic population with advanced microvascular disease.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>The study included 203 diabetic patients (117 male, 86 female) with proliferative diabetic retinopathy. Subjects were investigated by questionnaires, clinical examinations, blood and urine sampling, and review of medical records in the period from November 2008 through April 2009. Presence of DPN was defined as VPT \u226525\u2005V.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>The mean (\u00b1SD) age was 65.2 (\u00b19.9)\u2005years and median (IQR) diabetes duration was 18 (10\u201325)\u2005years. Forty-six per cent of subjects were found to have DPN, defined as a VPT \u226525\u2005V by neurothesiometer testing. Prevalence of DPN was found to be associated with age (p=0.038), male gender (p=0.046), low haemoglobin (p&amp;lt;0.001), high erythrocyte sedimentation rate (p=0.03), uric acid values (p=0.034), and peripheral vascular disease (PVD) (p=0.003) in univariate analysis. Multivariate logistic regression analysis revealed male gender (OR 5.52; p&amp;lt;0.001) and low haemoglobin values (B=\u22120.58; p&amp;lt;0.001) to be independent predictors of VPT \u226525\u2005V in subjects with proliferative retinopathy, while linear regression analysis revealed male gender (p&amp;lt;0.001), haemoglobin (p=0.001), age (p=0.04), and PVD (p=0.001) to be significant predictors of VPT.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>This study reports a novel independent association of DPN with low haemoglobin values. In the study population with type 2 DM and proliferative retinopathy, DPN was also independently associated with male gender, age, and PVD. Further studies are needed to confirm the association with low haemoglobin and identify the underlying mechanism.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/pgmj.2010.104216","type":"journal-article","created":{"date-parts":[[2011,9,27]],"date-time":"2011-09-27T10:53:40Z","timestamp":1317120820000},"page":"658-663","source":"Crossref","is-referenced-by-count":2,"title":["Predictors of vibration perception threshold in type 2 diabetic patients with proliferative retinopathy"],"prefix":"10.1093","volume":"87","author":[{"given":"Caroline Jane","family":"Magri","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Mater Dei Hospital , Tal-Qroqq, Msida, Malta"},{"name":"Department of Medicine, University of Malta Medical School , Tal-Qroqq, Msida, Malta"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neville","family":"Calleja","sequence":"additional","affiliation":[{"name":"Department of Health Information & Research , G\u2019Mangia, Malta"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerald","family":"Buhagiar","sequence":"additional","affiliation":[{"name":"Department of Pathology, Mater Dei Hospital , Tal-Qroqq, Msida, Malta"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Fava","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Malta Medical School , Tal-Qroqq, Msida, Malta"},{"name":"Diabetes and Endocrine Centre, Mater Dei Hospital , Tal-Qroqq, Msida, Malta"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josanne","family":"Vassallo","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Malta Medical School , Tal-Qroqq, Msida, Malta"},{"name":"Diabetes and Endocrine Centre, Mater Dei Hospital , Tal-Qroqq, Msida, Malta"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2011,9,27]]},"reference":[{"key":"2023041908451443300_b1","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/S0025-6196(11)61474-2","article-title":"Diabetic peripheral neuropathic pain: clinical and quality of issues","volume":"81","author":"Argoff","year":"2006","journal-title":"Mayo Clin Proc"},{"key":"2023041908451443300_b2","doi-asserted-by":"crossref","first-page":"617","DOI":"10.2337\/diacare.28.3.617","article-title":"Associations of mortality and diabetes complications in patients with type 1 and type 2 diabetes","volume":"28","author":"Cusick","year":"2005","journal-title":"Diabetes Care"},{"key":"2023041908451443300_b3","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1001\/jama.290.10.1371","article-title":"New insights into diabetic polyneuropathy","volume":"290","author":"Polydefkis","year":"2003","journal-title":"JAMA"},{"key":"2023041908451443300_b4","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJM199309303291401","article-title":"The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group","volume":"329","author":"DCCT","year":"1993","journal-title":"N Engl J Med"},{"key":"2023041908451443300_b5","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","article-title":"Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group","volume":"352","author":"UK Prospective Diabetes Study Group","year":"1998","journal-title":"Lancet"},{"key":"2023041908451443300_b6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1023\/A:1014409829614","article-title":"Retinopathy as a predictor of other diabetic complications","volume":"24","author":"El-Asrar","year":"2001","journal-title":"Int Ophthalmol"},{"key":"2023041908451443300_b7","first-page":"295","article-title":"Reproducibility of different methods for diagnosing and monitoring diabetic neuropathy","volume":"38","author":"Nasseri","year":"1998","journal-title":"Electromyogr Clin Neurophysiol"},{"key":"2023041908451443300_b8","doi-asserted-by":"crossref","first-page":"43","DOI":"10.4103\/0973-3930.60007","article-title":"A Comparative study of examination scores and quantitative sensory testing in diagnosis of diabetic polyneuropathy","volume":"30","author":"Mythili","year":"2010","journal-title":"Int J Diabetes Dev Ctries"},{"key":"2023041908451443300_b9","doi-asserted-by":"crossref","first-page":"557","DOI":"10.2337\/diacare.17.6.557","article-title":"The prediction of diabetic neuropathic foot ulceration using vibratory perception thresholds","volume":"17","author":"Young","year":"1994","journal-title":"Diabetes Care"},{"key":"2023041908451443300_b10","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.2337\/dc09-0554","article-title":"EURODIAB Prospective Complications Study Group: Large-fibre dysfunction in diabetic peripheral neuropathy is predicted by cardiovascular risk factors","volume":"32","author":"Elliott","year":"2009","journal-title":"Diabetes Care"},{"key":"2023041908451443300_b11","doi-asserted-by":"crossref","first-page":"317","DOI":"10.2337\/dc08-1250","article-title":"Peripheral sensory neuropathy associates with micro- or macroangiopathy: results from a population-based study of type 2 diabetic patients in Sweden","volume":"32","author":"K\u00e4rvestedt","year":"2009","journal-title":"Diabetes Care"},{"key":"2023041908451443300_b12","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1007\/s10016-006-9019-x","article-title":"Measurement, calculation, and normal range of the Ankle-Arm Index: a bibliometric analysis and recommendation for standardization","volume":"20","author":"Klein","year":"2006","journal-title":"Ann Vasc Surg"},{"key":"2023041908451443300_b13","first-page":"253","article-title":"Ankle-brachial index: a surrogate marker of microvascular complications in type 2 diabetes mellitus?","volume":"26","author":"Papanas","year":"2007","journal-title":"Int Angiol"},{"key":"2023041908451443300_b14","volume-title":"Calculator for Healthcare Professsionals","author":"National Kidney Foundation"},{"key":"2023041908451443300_b15","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/S0140-6736(05)67402-8","article-title":"IDF Epidemiology Task Force Concensus Group. The metabolic syndrome- a new worldwide definition","volume":"366","author":"Alberti","year":"2005","journal-title":"Lancet"},{"key":"2023041908451443300_b16","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and \u03b2 cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"2023041908451443300_b17","volume-title":"Chronic Kidney Disease: National Clinical Guideline for Early Identification and Management in Adults in Primary and Secondary Care","author":"National Collaborating Centre for Chronic Conditions","year":"2008"},{"key":"2023041908451443300_b18","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/S1473-3099(04)01109-0","article-title":"Peripheral neuropathy associated with prolonged use of linezolid","volume":"4","author":"Bressler","year":"2004","journal-title":"Lancet Infect Dis"},{"key":"2023041908451443300_b19","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1592\/phco.27.8.1189","article-title":"Linezolid-associated peripheral and optic neuropathy, lactic acidosis, and serotonin syndrome","volume":"27","author":"Narita","year":"2007","journal-title":"Pharmacotherapy"},{"key":"2023041908451443300_b20","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.2337\/diacare.28.5.1118","article-title":"Anemia and diabetes in the absence of nephropathy","volume":"28","author":"Craig","year":"2005","journal-title":"Diabetes Care"},{"key":"2023041908451443300_b21","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1053\/j.ajkd.2006.06.011","article-title":"The epidemiology of hemoglobin levels in patients with type 2 diabetes","volume":"48","author":"Thomas","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"2023041908451443300_b22","doi-asserted-by":"crossref","first-page":"156","DOI":"10.2337\/dc09-0606","article-title":"Association of metformin, elevated homocysteine, and methylmalonic acid levels and clinically worsened diabetic peripheral neuropathy","volume":"33","author":"Wile","year":"2010","journal-title":"Diabetes Care"},{"key":"2023041908451443300_b23","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1093\/tropej\/48.4.204","article-title":"Reversal of iron deficiency anemia-induced peripheral neuropathy by iron treatment in children with iron deficiency anemia","volume":"48","author":"Kabakus","year":"2002","journal-title":"J Trop Pediatr"},{"key":"2023041908451443300_b24","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1042\/CS20050291","article-title":"Haemoglobin and flow-mediated vasodilation","volume":"110","author":"Madsen","year":"2006","journal-title":"Clin Sci (Lond)"},{"key":"2023041908451443300_b25","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2215\/CJN.05080709","article-title":"The relationship between hemoglobin levels and endothelial functions in diabetes mellitus","volume":"5","author":"Sonmez","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"2023041908451443300_b26","doi-asserted-by":"crossref","first-page":"12916","DOI":"10.1074\/jbc.M700546200","article-title":"Concerted nitric oxide formation and release from the simultaneous reactions of nitrite with deoxy- and oxyhemoglobin","volume":"282","author":"Grubina","year":"2007","journal-title":"J Biol Chem."},{"key":"2023041908451443300_b27","doi-asserted-by":"crossref","first-page":"H1507","DOI":"10.1152\/ajpheart.00310.2006","article-title":"How do red blood cells cause hypoxic vasodilation? The SNO-hemoglobin paradigm","volume":"291","author":"Allen","year":"2006","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2023041908451443300_b28","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1172\/JCI24650","article-title":"Enzymatic function of hemoglobin as a nitrite reductase that produces NO under allosteric control","volume":"115","author":"Huang","year":"2005","journal-title":"J Clin Invest"},{"key":"2023041908451443300_b29","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1007\/BF00418351","article-title":"The impact of reversal of hypoxia by revascularization on the peripheral nerve function of diabetic patients","volume":"39","author":"Veves","year":"1996","journal-title":"Diabetologia"},{"key":"2023041908451443300_b30","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1007\/s00066-002-0925-8","article-title":"Anemia and elevated systemic levels of vascular endothelial growth factor (VEGF)","volume":"178","author":"Dunst","year":"2002","journal-title":"Strahlenther Onkol"},{"key":"2023041908451443300_b31","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1172\/JCI12188","article-title":"Reversal of experimental diabetic neuropathy by VEGF gene transfer","volume":"107","author":"Schratzberger","year":"2001","journal-title":"J Clin Invest"},{"key":"2023041908451443300_b32","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.semnephrol.2006.05.003","article-title":"The high prevalence of anaemia in diabetes is linked to functional erythropoietin deficiency","volume":"26","author":"Thomas","year":"2006","journal-title":"Semin Nephrol"},{"key":"2023041908451443300_b33","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1002\/1520-7560(200005\/06)16:3<172::AID-DMRR117>3.0.CO;2-D","article-title":"Blunted erythropoietin response to anemia in patients with type 1 diabetes","volume":"16","author":"Cotroneo","year":"2000","journal-title":"Diabetes Metab Res Rev"},{"key":"2023041908451443300_b34","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.expneurol.2007.09.018","article-title":"Erythropoietin and its carbamylated derivative prevent the development of experimental diabetic autonomic neuropathy in STZ-induced diabetic NOD-SCID mice","volume":"209","author":"Schmidt","year":"2008","journal-title":"Exp Neurol"},{"key":"2023041908451443300_b35","doi-asserted-by":"crossref","first-page":"509","DOI":"10.3174\/ajnr.A1820","article-title":"Erythropoietin promotes functional recovery and enhances nerve regeneration after peripheral nerve injury in rats","volume":"31","author":"Yin","year":"2010","journal-title":"AJNR Am J Neuroradiol"},{"key":"2023041908451443300_b36","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.ejca.2006.09.028","article-title":"Cisplatin-induced peripheral neuropathy: neuroprotection by erythropoietin without affecting tumour growth","volume":"43","author":"Bianchi","year":"2007","journal-title":"Eur J Cancer"},{"key":"2023041908451443300_b37","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1007\/s12264-010-0413-6","article-title":"Recombinant human erythropoietin counteracts cisplatin-induced visceral hyperalgesia","volume":"26","author":"Yoon","year":"2010","journal-title":"Neurosci Bull"},{"key":"2023041908451443300_b38","doi-asserted-by":"crossref","first-page":"577","DOI":"10.3923\/pjbs.2010.577.587","article-title":"Role of erythropoietin in prevention of chemotherapy-induced peripheral neuropathy","volume":"13","author":"Kassem","year":"2010","journal-title":"Pak J Biol Sci"},{"key":"2023041908451443300_b39","first-page":"121","article-title":"Effect of erythropoietin therapy on polyneuropathy in predialytic patients","volume":"16","author":"Hassan","year":"2003","journal-title":"J Nephrol"},{"key":"2023041908451443300_b40","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.neulet.2004.08.080","article-title":"Erythropoietin is neuroprotective in models of HIV sensory neuropathy","volume":"371","author":"Keswani","year":"2004","journal-title":"Neurosci Lett"},{"key":"2023041908451443300_b41","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1182\/blood-2004-02-0744","article-title":"Erythropoietin and hypoxia stimulate erythropoietin recaptor and nitric oxide production by endothelial cells","volume":"104","author":"Beleslin-Cokic","year":"2004","journal-title":"Blood"},{"key":"2023041908451443300_b42","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1182\/blood.V93.8.2627","article-title":"Human erythropoietin induces a pro-angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo","volume":"93","author":"Ribatti","year":"1999","journal-title":"Blood"},{"key":"2023041908451443300_b43","doi-asserted-by":"crossref","first-page":"5978","DOI":"10.1073\/pnas.87.15.5978","article-title":"Erythropoietin has a mitogenic and positive chemotactic effect on endothelial cells","volume":"87","author":"Anagnostou","year":"1990","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Postgraduate Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/pmj\/article-pdf\/87\/1032\/658\/50019304\/postgradmedj-87-658.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/pmj\/article-pdf\/87\/1032\/658\/50019304\/postgradmedj-87-658.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,19]],"date-time":"2023-04-19T08:57:22Z","timestamp":1681894642000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/pmj\/article\/87\/1032\/658\/7031970"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9,27]]},"references-count":43,"journal-issue":{"issue":"1032","published-online":{"date-parts":[[2011,9,27]]},"published-print":{"date-parts":[[2011,10,1]]}},"URL":"https:\/\/doi.org\/10.1136\/pgmj.2010.104216","relation":{},"ISSN":["1469-0756","0032-5473"],"issn-type":[{"value":"1469-0756","type":"electronic"},{"value":"0032-5473","type":"print"}],"subject":[],"published-other":{"date-parts":[[2011,10]]},"published":{"date-parts":[[2011,9,27]]}}}